258 related articles for article (PubMed ID: 32586379)
1. RBM45 associates with nuclear stress bodies and forms nuclear inclusions during chronic cellular stress and in neurodegenerative diseases.
Collins M; Li Y; Bowser R
Acta Neuropathol Commun; 2020 Jun; 8(1):91. PubMed ID: 32586379
[TBL] [Abstract][Full Text] [Related]
2. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.
Collins M; Riascos D; Kovalik T; An J; Krupa K; Krupa K; Hood BL; Conrads TP; Renton AE; Traynor BJ; Bowser R
Acta Neuropathol; 2012 Nov; 124(5):717-32. PubMed ID: 22993125
[TBL] [Abstract][Full Text] [Related]
3. Immunoprecipitation and mass spectrometry defines an extensive RBM45 protein-protein interaction network.
Li Y; Collins M; An J; Geiser R; Tegeler T; Tsantilas K; Garcia K; Pirrotte P; Bowser R
Brain Res; 2016 Sep; 1647():79-93. PubMed ID: 26979993
[TBL] [Abstract][Full Text] [Related]
4. RBM45 homo-oligomerization mediates association with ALS-linked proteins and stress granules.
Li Y; Collins M; Geiser R; Bakkar N; Riascos D; Bowser R
Sci Rep; 2015 Sep; 5():14262. PubMed ID: 26391765
[TBL] [Abstract][Full Text] [Related]
5. Family-based exome sequencing identifies RBM45 as a possible candidate gene for frontotemporal dementia and amyotrophic lateral sclerosis.
van der Zee J; Dillen L; Baradaran-Heravi Y; Gossye H; Koçoğlu C; Cuyt I; Dermaut B; Sieben A; Baets J; De Jonghe P; Vandenberghe R; De Deyn P; Cras P; Engelborghs S; Van Broeckhoven C;
Neurobiol Dis; 2021 Aug; 156():105421. PubMed ID: 34118419
[TBL] [Abstract][Full Text] [Related]
6. Developmentally Regulated RNA-binding Protein 1 (Drb1)/RNA-binding Motif Protein 45 (RBM45), a Nuclear-Cytoplasmic Trafficking Protein, Forms TAR DNA-binding Protein 43 (TDP-43)-mediated Cytoplasmic Aggregates.
Mashiko T; Sakashita E; Kasashima K; Tominaga K; Kuroiwa K; Nozaki Y; Matsuura T; Hamamoto T; Endo H
J Biol Chem; 2016 Jul; 291(29):14996-5007. PubMed ID: 27226551
[TBL] [Abstract][Full Text] [Related]
7. ALS-associated protein FIG4 is localized in Pick and Lewy bodies, and also neuronal nuclear inclusions, in polyglutamine and intranuclear inclusion body diseases.
Kon T; Mori F; Tanji K; Miki Y; Toyoshima Y; Yoshida M; Sasaki H; Kakita A; Takahashi H; Wakabayashi K
Neuropathology; 2014 Feb; 34(1):19-26. PubMed ID: 23888880
[TBL] [Abstract][Full Text] [Related]
8. RBM45 Modulates the Antioxidant Response in Amyotrophic Lateral Sclerosis through Interactions with KEAP1.
Bakkar N; Kousari A; Kovalik T; Li Y; Bowser R
Mol Cell Biol; 2015 Jul; 35(14):2385-99. PubMed ID: 25939382
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and pathological spectrum of TDP-43 associated ALS].
Onodera O; Yokoseki A; Tan CF; Ishihara T; Nishiira Y; Toyoshima Y; Kakita A; Nishizawa M; Takahashi H
Rinsho Shinkeigaku; 2010 Nov; 50(11):940-2. PubMed ID: 21921519
[TBL] [Abstract][Full Text] [Related]
10. TDP-43 in ubiquitinated inclusions in the inferior olives in frontotemporal lobar degeneration and in other neurodegenerative diseases: a degenerative process distinct from normal ageing.
Davidson Y; Amin H; Kelley T; Shi J; Tian J; Kumaran R; Lashley T; Lees AJ; DuPlessis D; Neary D; Snowden J; Akiyama H; Arai T; Hasegawa M; Bandopadhyay R; Sikkink S; Pickering-Brown S; Mann DM
Acta Neuropathol; 2009 Sep; 118(3):359-69. PubMed ID: 19330339
[TBL] [Abstract][Full Text] [Related]
11. Ultrastructural localization of TDP-43 in filamentous neuronal inclusions in various neurodegenerative diseases.
Lin WL; Dickson DW
Acta Neuropathol; 2008 Aug; 116(2):205-13. PubMed ID: 18607609
[TBL] [Abstract][Full Text] [Related]
12. Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis.
Tan RH; Yang Y; Kim WS; Dobson-Stone C; Kwok JB; Kiernan MC; Halliday GM
Acta Neuropathol Commun; 2017 Oct; 5(1):76. PubMed ID: 29078806
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of the sigma-1 receptor is common to neuronal nuclear inclusions in various neurodegenerative diseases.
Miki Y; Mori F; Kon T; Tanji K; Toyoshima Y; Yoshida M; Sasaki H; Kakita A; Takahashi H; Wakabayashi K
Neuropathology; 2014 Apr; 34(2):148-58. PubMed ID: 24313828
[TBL] [Abstract][Full Text] [Related]
14. FUS-immunoreactive intranuclear inclusions in neurodegenerative disease.
Woulfe J; Gray DA; Mackenzie IR
Brain Pathol; 2010 May; 20(3):589-97. PubMed ID: 19832837
[TBL] [Abstract][Full Text] [Related]
15. Valosin-containing protein immunoreactivity in tauopathies, synucleinopathies, polyglutamine diseases and intranuclear inclusion body disease.
Mori F; Tanji K; Toyoshima Y; Sasaki H; Yoshida M; Kakita A; Takahashi H; Wakabayashi K
Neuropathology; 2013 Dec; 33(6):637-44. PubMed ID: 23782134
[TBL] [Abstract][Full Text] [Related]
16. Suppression of Progranulin Expression Leads to Formation of Intranuclear TDP-43 Inclusions In Vitro: A Cell Model of Frontotemporal Lobar Degeneration.
Zhu J; Wang N; Li X; Zheng X; Zhao J; Xia H; Mao Q
J Neuropathol Exp Neurol; 2019 Dec; 78(12):1124-1129. PubMed ID: 31626287
[TBL] [Abstract][Full Text] [Related]
17. Transportin 1 accumulates specifically with FET proteins but no other transportin cargos in FTLD-FUS and is absent in FUS inclusions in ALS with FUS mutations.
Neumann M; Valori CF; Ansorge O; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ishihara K; Ang LC; Bilbao JM; Mackenzie IR
Acta Neuropathol; 2012 Nov; 124(5):705-16. PubMed ID: 22842875
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneous nuclear ribonucleoproteins R and Q accumulate in pathological inclusions in FTLD-FUS.
Gittings LM; Foti SC; Benson BC; Gami-Patel P; Isaacs AM; Lashley T
Acta Neuropathol Commun; 2019 Feb; 7(1):18. PubMed ID: 30755280
[TBL] [Abstract][Full Text] [Related]
19. Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam.
Geser F; Winton MJ; Kwong LK; Xu Y; Xie SX; Igaz LM; Garruto RM; Perl DP; Galasko D; Lee VM; Trojanowski JQ
Acta Neuropathol; 2008 Jan; 115(1):133-45. PubMed ID: 17713769
[TBL] [Abstract][Full Text] [Related]
20. TAR DNA-binding protein 43 in neurodegenerative disease.
Chen-Plotkin AS; Lee VM; Trojanowski JQ
Nat Rev Neurol; 2010 Apr; 6(4):211-20. PubMed ID: 20234357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
